PSMA PET/CT for tyrosine-kinase inhibitor monitoring in metastatic renal cell carcinoma

被引：10
|
作者：
Mittlmeier, L. M. [1 ,2 ]
Unterrainer, M. [2 ,3 ]
Todica, A. [2 ]
Cyran, C. C. [3 ]
Rodler, S. [1 ]
Bartenstein, P. [2 ]
Stief, C. G. [1 ]
Ilhan, H. [2 ]
Staehler, M. [1 ]
机构：
[1] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Urol, Munich, Germany
[2] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Nucl Med, Munich, Germany
[3] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Radiol, Munich, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2020年 / 47卷 / 09期
关键词：
D O I：
10.1007/s00259-019-04636-6
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
[No abstract available]
引用
收藏
页码：2216 / 2217
页数：2
相关论文
共 50 条
  • [1] PSMA PET/CT for tyrosine-kinase inhibitor monitoring in metastatic renal cell carcinoma
    L. M. Mittlmeier
    M. Unterrainer
    A. Todica
    C. C. Cyran
    S. Rodler
    P. Bartenstein
    C. G. Stief
    H. Ilhan
    M. Staehler
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 2216 - 2217
  • [2] 18F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine-kinase and check-point inhibitor therapy - preliminary results
    Mittlmeier, Lena
    Unterrainer, Marcus
    Todica, Andrei
    Cyran, Clemens
    Rodler, Severin
    Bartenstein, Peter
    Stief, Christian
    Staehler, Michael
    Ilhan, Harun
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [3] 18F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy
    Mittlmeier, L.
    Unterrainer, M.
    Rodler, S.
    Todica, A.
    Albert, N. L.
    Burgard, C.
    Cyran, C. C.
    Kunz, W. G.
    Ricke, J.
    Bartenstein, P.
    Stief, C. G.
    Staehler, M.
    Ilhan, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S283 - S284
  • [4] Tyrosine-kinase inhibitor sorafenib (S) in treatment of metastatic renal cell carcinoma cancer (mRCC) with lung metastases
    Popova, Irina L.
    Vladimirova, Liubov Yu
    Abramova, Natalya A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [5] Panniculitis in a patient with metastatic renal cell carcinoma on a tyrosine kinase inhibitor
    Nafissi, Nellie N.
    Karlin, Nina
    Pittelkow, Mark R.
    Dicaudo, David J.
    Mangold, Aaron R.
    ANTI-CANCER DRUGS, 2021, 32 (04) : 474 - 475
  • [6] 18F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary results
    L. M. Mittlmeier
    M. Unterrainer
    S. Rodler
    A. Todica
    N. L. Albert
    C. Burgard
    C. C. Cyran
    W. G. Kunz
    J. Ricke
    P. Bartenstein
    C. G. Stief
    H. Ilhan
    M. Staehler
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 2031 - 2037
  • [7] 18F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary results
    Mittlmeier, L. M.
    Unterrainer, M.
    Rodler, S.
    Todica, A.
    Albert, N. L.
    Burgard, C.
    Cyran, C. C.
    Kunz, W. G.
    Ricke, J.
    Bartenstein, P.
    Stief, C. G.
    Ilhan, H.
    Staehler, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (06) : 2031 - 2037
  • [8] 18F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing first line tyrosine kinase or checkpoint inhibitor therapy.
    Staehler, Michael D.
    Kunte, Sophie
    Holzgreve, Adrien
    Unterrainer, Marcus
    Blajan, Iulia
    Stief, Christian G.
    Bartenstein, Peter
    Casuscelli, Jozefina
    Unterrainer, Lena
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [9] Predictive value of De Ritis ratio in metastatic renal cell carcinoma treated with tyrosine-kinase inhibitors
    Florian Janisch
    Thomas Klotzbücher
    Phillip Marks
    Christina Kienapfel
    Christian P. Meyer
    Hang Yu
    Constantin Fühner
    Tobias Hillemacher
    Keiichiro Mori
    Hadi Mostafei
    Shahrokh F. Shariat
    Margit Fisch
    Roland Dahlem
    Michael Rink
    World Journal of Urology, 2021, 39 : 2977 - 2985
  • [10] Predictive value of De Ritis ratio in metastatic renal cell carcinoma treated with tyrosine-kinase inhibitors
    Janisch, Florian
    Klotzbuecher, Thomas
    Marks, Phillip
    Kienapfel, Christina
    Meyer, Christian P.
    Yu, Hang
    Fuehner, Constantin
    Hillemacher, Tobias
    Mori, Keiichiro
    Mostafei, Hadi
    Shariat, Shahrokh F.
    Fisch, Margit
    Dahlem, Roland
    Rink, Michael
    WORLD JOURNAL OF UROLOGY, 2021, 39 (08) : 2977 - 2985
12345